Back
Givaudan SA Vs. Corcept Therapeutics Industry Stock Comparison
Buy
54
GVDNY
Givaudan SA
Last Price:
$85.71
Seasonality Move:
5.65%
Sell
49
CORT
Corcept Therapeutics
Last Price:
$73.54
Seasonality Move:
6.42%
Buy
54
Givaudan SA (GVDNY)
is a Buy
Is Givaudan SA a Buy, Sell or Hold?
-
The current Givaudan SA [GVDNY] share price is $82.51. The Score for GVDNY is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
GVDNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Corcept Therapeutics (CORT)
is a Sell
Is Corcept Therapeutics a Buy, Sell or Hold?
-
The current Corcept Therapeutics [CORT] share price is $70.49. The Score for CORT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
CORT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GVDNY Stock Price Chart
What is Givaudan SA's stock price today?
-
The Givaudan SA share price today is $82.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GVDNY is experiencing slight selling pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $70.49The current trend is moderately bullish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
GVDNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.01 | Sell |
Relative Strength Index (14 RSI): | 36.35 | Sell |
Chaikin Money Flow: | -18866 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (85.78 - 91.1) | Sell |
Bollinger Bands (100): | (85.65 - 89.83) | Sell |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 19.38 | Buy |
Relative Strength Index (14 RSI): | 51.56 | Buy |
Chaikin Money Flow: | -1501450 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.77 - 78.73) | Buy |
Bollinger Bands (100): | (50.86 - 69.62) | Buy |
GVDNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.19 | Sell |
20-day SMA: | 87.95 | Sell |
50-day SMA: | 87.88 | Sell |
200-day SMA: | 93.63 | Sell |
8-day EMA: | 85.76 | Sell |
20-day EMA: | 87.12 | Sell |
50-day EMA: | 87.92 | Sell |
200-day EMA: | 89.85 | Sell |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 80.44 | Sell |
20-day SMA: | 66.48 | Buy |
50-day SMA: | 65.09 | Buy |
200-day SMA: | 49.31 | Buy |
8-day EMA: | 73.23 | Sell |
20-day EMA: | 55.49 | Buy |
50-day EMA: | 30.9 | Buy |
200-day EMA: | 9.29 | Buy |
Givaudan SA Earnings Growth & GVDNY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.
Givaudan SA Technical Analysis
Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |